Description: Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.
Home Page: www.pasithea.com
KTTA Technical Analysis
1111 Lincoln Road
Miami Beach,
FL
33139
United States
Phone:
702 514 4174
Officers
| Name | Title |
|---|---|
| Dr. Lawrence Steinman BA, M.D. | Exec. Chairman & Co-Founder |
| Dr. Tiago Reis Marques | CEO & Director |
| Mr. Daniel H. Schneiderman | Chief Financial Officer |
| Dr. Yassine Bendiabdallah Ph.D. | COO & Head of UK Clinics |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6064 |
| Price-to-Sales TTM: | 93.068 |
| IPO Date: | 2021-09-15 |
| Fiscal Year End: | December |
| Full Time Employees: | 3 |